Charles Schwab’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1M | Buy |
|
|||||
|
2025
Q1 | $20.4M | Buy |
|
|||||
|
2024
Q4 | $22.7M | Buy |
|
|||||
|
2024
Q3 | $16.2M | Buy |
|
|||||
|
2024
Q2 | $11.7M | Buy |
|
|||||
|
2024
Q1 | $9.81M | Buy |
|
|||||
|
2023
Q4 | $6.96M | Sell |
|
|||||
|
2023
Q3 | $7M | Buy |
|
|||||
|
2023
Q2 | $4.77M | Buy |
|
|||||
|
2023
Q1 | $5.42M | Sell |
|
|||||
|
2022
Q4 | $5.65M | Sell |
|
|||||
|
2022
Q3 | $5.06M | Buy |
|
|||||
|
2022
Q2 | $4.54M | Buy |
|
|||||
|
2022
Q1 | $5.5M | Buy |
|
|||||
|
2021
Q4 | $4.53M | Buy |
|
|||||
|
2021
Q3 | $5.34M | Buy |
|
|||||
|
2021
Q2 | $5.25M | Hold |
|
|||||
|
2021
Q1 | $6.13M | Buy |
|
|||||
|
2020
Q4 | $4.86M | Buy |
|
|||||
|
2020
Q3 | $4.42M | Buy |
|
|||||
|
2020
Q2 | $5.89M | Buy |
|
|||||
|
2020
Q1 | $4.17M | Buy |
|
|||||
|
2019
Q4 | $4.13M | Buy |
|
|||||
|
2019
Q3 | $2.83M | Buy |
|
|||||
|
2019
Q2 | $3.65M | Buy |
|
|||||
|
2019
Q1 | $5.34M | Buy |
|
|||||
|
2018
Q4 | $5.05M | Buy |
|
|||||
|
2018
Q3 | $6.6M | Buy |
|
|||||
|
2018
Q2 | $7.23M | Buy |
|
|||||
|
2018
Q1 | $4.73M | Buy |
|
|||||
|
2017
Q4 | $5.02M | Buy |
|
|||||
|
2017
Q3 | $4.36M | Buy |
|
|||||
|
2017
Q2 | $8.03M | Buy |
|
|||||
|
2017
Q1 | $7.2M | Hold |
|
|||||
|
2016
Q4 | $8.14M | Buy |
|